Search PDMR transactions

Notifier
Name
Daniel Patrick Mackey
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Daniel Patrick Mackey
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name
Infant Bacterial Therapeutics AB
LEI of Issuer
2138008KVBXCRJGP6Z26
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Infant Bacterial Therapeutics AB SE0008015259 Acquisition 400 Quantity 104.50 SEK 12/03/2021 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Infant Bacterial Therapeutics AB SE0008015259 Acquisition 12/03/2021 NASDAQ STOCKHOLM AB 400 (Quantity) 104.50 SEK
Total: 400
<< Back